SK8952002A3 - Pyrazolo[1,5-d][1,2,4]triazine derivatives, method for their preparation, pharmaceutical composition containing them and use thereof - Google Patents
Pyrazolo[1,5-d][1,2,4]triazine derivatives, method for their preparation, pharmaceutical composition containing them and use thereof Download PDFInfo
- Publication number
- SK8952002A3 SK8952002A3 SK895-2002A SK8952002A SK8952002A3 SK 8952002 A3 SK8952002 A3 SK 8952002A3 SK 8952002 A SK8952002 A SK 8952002A SK 8952002 A3 SK8952002 A3 SK 8952002A3
- Authority
- SK
- Slovakia
- Prior art keywords
- alkyl
- methyl
- pyrazolo
- optionally substituted
- tert
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9927874.9A GB9927874D0 (en) | 1999-11-25 | 1999-11-25 | Therapeutic agents |
GB0009602A GB0009602D0 (en) | 2000-04-18 | 2000-04-18 | Therapeutic agents |
GB0018651A GB0018651D0 (en) | 2000-07-28 | 2000-07-28 | Therapeutic agents |
PCT/GB2000/004450 WO2001038331A2 (en) | 1999-11-25 | 2000-11-22 | Pyrazolo[1,5-d][1,2,4]triazines for enhancing cognition |
Publications (1)
Publication Number | Publication Date |
---|---|
SK8952002A3 true SK8952002A3 (en) | 2002-10-08 |
Family
ID=27255677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK895-2002A SK8952002A3 (en) | 1999-11-25 | 2000-11-22 | Pyrazolo[1,5-d][1,2,4]triazine derivatives, method for their preparation, pharmaceutical composition containing them and use thereof |
Country Status (20)
Country | Link |
---|---|
US (1) | US6355638B1 (zh) |
EP (1) | EP1235829A2 (zh) |
JP (1) | JP2003514909A (zh) |
KR (1) | KR20020053091A (zh) |
CN (1) | CN1391574A (zh) |
AU (1) | AU1533001A (zh) |
BG (1) | BG106734A (zh) |
BR (1) | BR0015126A (zh) |
CA (1) | CA2391103A1 (zh) |
CZ (1) | CZ20021813A3 (zh) |
EA (1) | EA200200599A1 (zh) |
EE (1) | EE200200260A (zh) |
HK (1) | HK1046406A1 (zh) |
HU (1) | HUP0203579A3 (zh) |
IL (1) | IL149051A0 (zh) |
MX (1) | MXPA02005233A (zh) |
NO (1) | NO20022456D0 (zh) |
PL (1) | PL355637A1 (zh) |
SK (1) | SK8952002A3 (zh) |
WO (1) | WO2001038331A2 (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0128499D0 (en) * | 2001-11-28 | 2002-01-23 | Merck Sharp & Dohme | Therapeutic agents |
EP2298296A1 (en) * | 2009-08-25 | 2011-03-23 | CNRS Centre National De La Recherche Scientifique | Composition and method for treating cognitive impairments in down syndrome subjects |
EP2576540B1 (en) * | 2010-05-26 | 2019-09-04 | Sunovion Pharmaceuticals Inc. | Heteroaryl compounds and methods of use thereof |
US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
CN107344936B (zh) * | 2016-05-06 | 2022-06-03 | 上海赛默罗生物科技有限公司 | 三唑哒嗪类衍生物、其制备方法、药物组合物和用途 |
CN107344938B (zh) * | 2016-05-06 | 2022-05-06 | 上海赛默罗生物科技有限公司 | 吡唑-三嗪类衍生物、其制备方法、药物组合物和用途 |
CN114258390A (zh) * | 2019-06-19 | 2022-03-29 | 生物马林药物股份有限公司 | 用于疾病治疗的乙醇酸氧化酶抑制剂 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69720732T2 (de) * | 1996-07-25 | 2004-01-29 | Merck Sharp & Dohme | Substituierte Triazolo-Pyridazin-Derivate als Liganden von GABA-Rezeptoren |
GB9715977D0 (en) * | 1997-07-29 | 1997-10-01 | Merck Sharp & Dohme | Therapeutic agents |
EP1047697A1 (en) * | 1998-01-14 | 2000-11-02 | MERCK SHARP & DOHME LTD. | Triazolo-pyridazine derivatives as ligands for gaba receptors |
GB9806102D0 (en) * | 1998-03-20 | 1998-05-20 | Merck Sharp & Dohme | Therapeutic agents |
JP2002518391A (ja) * | 1998-06-16 | 2002-06-25 | メルク シャープ エンド ドーム リミテッド | Gaba受容体のリガンドとしてのトリアゾロ−ピリジン誘導体 |
EP1121361B1 (en) * | 1998-10-16 | 2007-08-29 | Merck Sharp & Dohme Limited | Pyrazolo-triazine derivatives as ligands for gaba receptors |
-
2000
- 2000-11-21 US US09/717,423 patent/US6355638B1/en not_active Expired - Lifetime
- 2000-11-22 KR KR1020027006672A patent/KR20020053091A/ko not_active Application Discontinuation
- 2000-11-22 WO PCT/GB2000/004450 patent/WO2001038331A2/en not_active Application Discontinuation
- 2000-11-22 PL PL00355637A patent/PL355637A1/xx not_active Application Discontinuation
- 2000-11-22 EE EEP200200260A patent/EE200200260A/xx unknown
- 2000-11-22 HU HU0203579A patent/HUP0203579A3/hu unknown
- 2000-11-22 MX MXPA02005233A patent/MXPA02005233A/es not_active Application Discontinuation
- 2000-11-22 AU AU15330/01A patent/AU1533001A/en not_active Abandoned
- 2000-11-22 EA EA200200599A patent/EA200200599A1/ru unknown
- 2000-11-22 CN CN00816013A patent/CN1391574A/zh active Pending
- 2000-11-22 IL IL14905100A patent/IL149051A0/xx unknown
- 2000-11-22 JP JP2001540094A patent/JP2003514909A/ja not_active Withdrawn
- 2000-11-22 BR BR0015126-2A patent/BR0015126A/pt not_active Application Discontinuation
- 2000-11-22 SK SK895-2002A patent/SK8952002A3/sk unknown
- 2000-11-22 CA CA002391103A patent/CA2391103A1/en not_active Abandoned
- 2000-11-22 EP EP00977692A patent/EP1235829A2/en not_active Withdrawn
- 2000-11-22 CZ CZ20021813A patent/CZ20021813A3/cs unknown
-
2002
- 2002-05-22 BG BG106734A patent/BG106734A/xx unknown
- 2002-05-24 NO NO20022456A patent/NO20022456D0/no not_active Application Discontinuation
- 2002-10-29 HK HK02107821.8A patent/HK1046406A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
BR0015126A (pt) | 2002-07-02 |
IL149051A0 (en) | 2002-11-10 |
KR20020053091A (ko) | 2002-07-04 |
BG106734A (en) | 2003-02-28 |
HUP0203579A2 (hu) | 2003-03-28 |
HUP0203579A3 (en) | 2003-07-28 |
NO20022456L (no) | 2002-05-24 |
EE200200260A (et) | 2003-06-16 |
US6355638B1 (en) | 2002-03-12 |
CZ20021813A3 (cs) | 2002-08-14 |
HK1046406A1 (zh) | 2003-01-10 |
PL355637A1 (en) | 2004-05-04 |
CN1391574A (zh) | 2003-01-15 |
EA200200599A1 (ru) | 2002-12-26 |
CA2391103A1 (en) | 2001-05-31 |
WO2001038331A2 (en) | 2001-05-31 |
MXPA02005233A (es) | 2002-11-07 |
WO2001038331A3 (en) | 2001-11-08 |
NO20022456D0 (no) | 2002-05-24 |
JP2003514909A (ja) | 2003-04-22 |
EP1235829A2 (en) | 2002-09-04 |
AU1533001A (en) | 2001-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6200975B1 (en) | Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as GABA alpha 5 ligands | |
ES2271221T3 (es) | Derivados imidazo-pirimidina como ligandos para receptores gaba. | |
US6313125B1 (en) | Therapeutically active 1,2,4-triazolo[4.,3-B] pyridazine derivatives as ligands for GABA receptors | |
WO2002081474A1 (en) | Triazolophthalazine / quinoline / isoquinoline derivatives which are ligands for gaba-a receptors containing the alpha 5 subtype | |
ES2208404T3 (es) | Derivados de imidazo-triazina como ligandos de los receptores de3 gaba. | |
JP2002501067A (ja) | Gaba受容体に対するリガンドとしてのトリアゾロ−ピリダジン誘導体 | |
US7144887B2 (en) | Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition | |
US6949549B2 (en) | Imidazolophthalazine derivatives as ligands for GABAA receptors | |
US6297235B1 (en) | Triazolopyridazine derivatives for treating anxiety and enhancing cognition | |
SK8952002A3 (en) | Pyrazolo[1,5-d][1,2,4]triazine derivatives, method for their preparation, pharmaceutical composition containing them and use thereof | |
US6613766B1 (en) | Pentaaza-cyclopental[a]naphthalene derivatives as ligands for GABAa α5 receptors | |
US6946461B2 (en) | Imidazolophthalazine derivatives as ligands for GABAA receptors | |
US6444666B1 (en) | Triazolopyridazine Derivatives for treating anxiety and enhancing cognition | |
US7022724B2 (en) | Cognition enhancing derivatives of isoxazole triazoloindane GABA-A α5 receptor subunit ligands | |
TW202317577A (zh) | 新穎化合物 |